Oxidative metabolism in platelets, platelet... (2005 study) Skip to main content
Clinical Study Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2005

Oxidative metabolism in platelets, platelet aggregation, and hematology in patients undergoing multiple hyperbaric oxygen exposures.

Handy RD, Bryson P, Moody AJ, Handy LM, Sneyd JR, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2005

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers drew blood from 31 patients before and after their 1st and 20th hyperbaric oxygen treatments to check for changes in platelets and blood cell counts.

What They Found

In this study of 31 patients getting repeated hyperbaric oxygen (HBO2) treatments at 2.2 ATA for 90 minutes each, the researchers found no evidence that 20 sessions caused adverse effects on platelet aggregation, platelet oxidative metabolism, red or white cell counts, or total antioxidant status of the plasma. Red cell counts, hematocrit, hemoglobin, platelet counts and plasma protein showed no effect of HBO2. Mean lymphocyte count was 38% higher after the 20th treatment, platelet protein content was 23% higher, and arachidonic acid-dependent platelet activation was 24% higher. Plasma lactate fell from 3.2 to 2.5 mmol/l by the end of the study. In smokers, the capacity for oxidative metabolism in platelets increased by the 20th treatment.

What This Means for Canadian Patients

The abstract says these treatments are used for chronically ill patients with problem wounds, and that there were concerns about oxygen's effect on blood cells and platelets. In this group of 31 patients, 20 sessions at 2.2 ATA did not produce adverse effects on the measures the researchers tracked. The abstract also reports some changes, such as higher lymphocyte counts and higher arachidonic acid-dependent platelet activation, and it does not say what these changes mean for patients.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract describes a single group of 31 patients with no comparison group that did not receive HBO2, so it cannot show that the changes seen were caused by the treatment, and only the 1st and 20th sessions were sampled.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Wound Care
Source Pubmed
PubMed ID 16457082
Year Published 2005
Journal Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
MeSH Terms Acetaminophen; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analysis of Variance; Blood Glucose; Blood Platelets; Erythrocyte Count; Erythrocyte Indices; Female; Hematocrit; Humans; Hyperbaric Oxygenation; Lactic Acid; Male

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology